How peptides are regulated

The four lanes

Any peptide sits in one of four lanes — and people constantly mix them up. A peptide can be an approved drug that cleared full FDA review and is legal to prescribe and sell as medicine (rare for peptides).S1 It can be compounded — prepared by a licensed pharmacy without full approval, legal only under specific conditions, which is not the same as being FDA-approved.S1 It can be a dietary supplement, a separate legal track for ingredients that qualify under the supplement law.S4 Or it can be a gray-market "research chemical", sold "for research use only, not for human consumption" — not legal to sell for human use, with no FDA oversight of what's in the vial.S1

Anti-doping status is a separate overlay: a substance can be a legal supplement and still banned in sport, or vice versa.S2

The compounding gates

To be compounded from a bulk substance, a peptide has to clear one gate: it has an official quality monograph, it's a component of an approved drug, or it's on the 503A Bulks List.S1 Getting onto that list is a multi-step process, and each step gets mistaken for the finish line: a substance is nominated, then sorted into Category 1 (no significant safety flag during review) or Category 2 (may present safety risks — don't compound meanwhile), or its nomination is withdrawn.S2 An advisory committee (PCAC) then recommends yes or no, FDA decides, and if yes does rulemaking to actually add it to the list.S3

Three common mix-ups

"Removed from Category 2 means it's legal." No — removal is a procedural step; it does not put a substance on the 503A list and does not make it eligible to compound.S2 "The advisory committee decides." No — PCAC only recommends; FDA makes the decision and then has to do rulemaking.S3 "Compounded means FDA-approved." No — compounding is an exception to approval, not a form of it.S1

Where the peptides sit

Every compound on this site is mapped to its lane and stage on the status map — from FDA-approved drugs, to peptides under active PCAC review, to the many that sit in the gray market. The key takeaway carries across all of them: being for sale is not the same as being proven, legal, or safe.